Phase 3 Study of Yimitasvir Phosphate Capsules

PHASE3CompletedINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

April 17, 2018

Primary Completion Date

March 28, 2019

Study Completion Date

June 25, 2019

Conditions
Chronic HCV Infection
Interventions
DRUG

SOF

400 mg tablet administered orally once daily

DRUG

DAG181

100 mg capsule administered orally once daily

Trial Locations (35)

100020

Beijing Ditan Hospital Affiliated to Capital Medical University, Beijing

100034

Peking University First Hospital, Beijing

100044

Peking University People's Hospital, Beijing

100050

Beijing Friendship Hospital,Capital Medical University, Beijing

100069

Beijing YouAn Hospital,Capital Medical University, Beijing

110006

The Sixth People's Hospital of Shenyang, Shenyang

130021

The First Hospital of Jilin University, Changchun

200020

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

201500

Shanghai Public Health Clinical Center, Shanghai

210002

The People's Liberation Army No.81 Hospital, Nanjing

210003

The Second Hospital of Nanjing, Nanjing

212004

The Third People's Hospital of Zhenjiang, Zhenjiang

214073

The Fifth People's Hospital of Wuxi, Wuxi

221002

The Affiliated Hospital of Xuzhou Medical Hospital, Xuzhou

325000

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

330006

The First Affiliated Hospital of NanChang University, Nanchang

350005

The First Affiliated Hospital of Fujian Medical University, Fuzhou

350025

Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou

410000

Hunan Provincial People's Hospital, Changsha

410008

Xiangya Hospital, Central South University, Changsha

430010

The Central Hospital of Wuhan, Wuhan

430022

Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology, Wuhan

430030

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University Science & Technology, Wuhan

430060

Renmin Hospital of Wuhan University, Wuhan

450003

People's Hospital of Zhengzhou, Zhengzhou

453100

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang

510060

Guangzhou Eighth People's Hospital, Guangzhou

510515

Nanfang Hospital of Southern Medical University, Guangzhou

570311

Hainan General Hospital, Haikou

610041

West China Hospital, Sichuan University, Chengdu

610072

Sichuan Provincial People's Hospital, Chengdu

710038

Tangdu Hospital, Xi’an

710061

The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

730000

The First Hospital of Lanzhou University, Lanzhou

050051

The Third Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY

NCT03487107 - Phase 3 Study of Yimitasvir Phosphate Capsules | Biotech Hunter | Biotech Hunter